Iovance Biotherapeutics has made progress in developing potency assays for lifileucel, a tumor-infiltrating lymphocyte therapy for advanced melanoma patients. Developing potency assays for lifileucel ...

Explore the latest developments showcased at World ADC, highlighting smarter payloads and precise targeting in drug discovery.

Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...

Antibody-drug conjugates (ADCs) continue to reshape the oncology landscape by combining the target specificity of monoclonal antibodies (mAbs) with the potent cytotoxicity of small-molecule drugs.

With so many customers working on cutting-edge cancer treatments, CDMO Novasep says demand for antibody-drug conjugate manufacturing is booming. Heeding the call, Novasep on Wednesday said it plans to ...

Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived ...